HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated membrane association of phospholipase C-gamma 1 in MDA-468 mammary tumor cells.

Abstract
We have examined the distribution of phospholipase C-gamma 1 (PLC-gamma 1) between membrane and cytosolic fractions in several cell lines. In MDA-468 cells, which are derived from a human breast tumor, greater than one-half of the total PLC-gamma 1 is associated with the membrane fraction of the cell. Unlike the situation in A-431 cells [G. Todderud, M. I. Wahl, S. G. Ree, and G. Carpenter, Science, 248: 296-298, 1990], epidermal growth factor (EGF) stimulation of MDA-468 cells does not result in significantly increased PLC-gamma 1 association with membranes. Immunoblot analysis reveals low levels of phosphotyrosine in PLC-gamma 1 and EGF receptors in unstimulated MDA-468 cells and greatly increased phosphotyrosine levels in these proteins as a result of EGF stimulation of the cells. We conclude that autocrine activation of EGF receptors is not responsible for the elevated association of PLC-gamma 1 with membranes in these cells.
AuthorsA M Soderquist, G Todderud, G Carpenter
JournalCancer research (Cancer Res) Vol. 52 Issue 16 Pg. 4526-9 (Aug 15 1992) ISSN: 0008-5472 [Print] United States
PMID1643644 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Isoenzymes
  • Epidermal Growth Factor
  • ErbB Receptors
  • Protein-Tyrosine Kinases
  • Type C Phospholipases
Topics
  • Animals
  • Cell Membrane (chemistry)
  • Cytosol (chemistry)
  • Electrophoresis, Polyacrylamide Gel
  • Epidermal Growth Factor (pharmacology)
  • ErbB Receptors (analysis, metabolism)
  • Isoenzymes (analysis, metabolism)
  • Mammary Neoplasms, Experimental (chemistry, metabolism)
  • Phosphorylation
  • Protein-Tyrosine Kinases (metabolism)
  • Tumor Cells, Cultured
  • Type C Phospholipases (analysis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: